Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
crispr
2
×
alphabet
bio
biology
biotech
boston blog main
boston top stories
broad institute of harvard and mit
brook byers
charles chu
crispr cas14
deals
decheng capital
diagnostic
drama
editas medicine
enzymes
genetics
google
infectious disease
investing
jennifer doudna
kleiner perkins
life sciences
mammoth biosciences
mayfield
medical devices
national blog main
national top stories
nfx
patent
san francisco
san francisco blog main
san francisco top stories
sherlock biosciences
startups
trevor martin
university of california berkeley
university of california san francisco
verily
What
cas
2
×
crispr
set
2
×
argument
arguments
available
based
begin
berkeley’s
big
bio
biosciences
charpentier
cheaper
colleague
court
date
december
develop
diagnostics
doudna
editing
emmanuelle
expects
faster
feng
gene
head
institute
jennifer
judges
mammoth
max
mit’s
month
office
oral
owns
patent
planck
Language
unset
Current search:
cas
×
crispr
×
set
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@techcrunch.com
7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
